Olema Pharmaceuticals, Inc.
Total Trades
52
Buys
5
Sells
36
Largest Trade
N/A
Insiders
11
Institutional Funds
146
Inst. Value
$1M+
Activist Filings
36
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Mitchell Shawnte | CHIEF LEGAL OFFICER | EXERCISE | $100K–$500K | 40K | $4.37 | Mar 6, 2026 |
| Mitchell Shawnte | CHIEF LEGAL OFFICER | SELL | $500K+ | 40K | $23.79 | Mar 6, 2026 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 10K | $26.88 | Jan 22, 2026 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 3K | $29.12 | Jan 17, 2026 |
| Kovacs Shane William Charles | CH. OPERATING & FI… | SELL | $1M+ | 104K | $28.70 | Jan 16, 2026 |
| Myles David C. | CH. DISCOV. & NON-… | EXERCISE | $100K–$500K | 100K | $4.87 | Jan 15, 2026 |
| Myles David C. | CH. DISCOV. & NON-… | SELL | $1M+ | 110K | $28.25 | Jan 15, 2026 |
| Harmon Cyrus | Director | SELL | $50K–$100K | 3K | $28.53 | Dec 30, 2025 |
| CLARK IAN T | Director | SELL | $1M+ | 265K | $29.73 | Dec 24, 2025 |
| CLARK IAN T | Director | EXERCISE | $1M+ | 265K | $4.61 | Dec 24, 2025 |
| Myles David C. | CH. DISCOV. & NON-… | SELL | $1M+ | 51K | $30.46 | Dec 24, 2025 |
| Zojwalla Naseem | Chief Medical Offi… | SELL | $1M+ | 270K | $27.94 | Dec 24, 2025 |
| Zojwalla Naseem | Chief Medical Offi… | EXERCISE | $1M+ | 140K | $11.89 | Dec 24, 2025 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 25K | $8.19 | Sep 19, 2025 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | BUY | $1M+ | 300K | $5.76 | Jan 13, 2025 |
| Harmon Cyrus | Director | SELL | $50K–$100K | 5K | $15.57 | Jul 31, 2024 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 20K | $10.77 | Jul 2, 2024 |
| Graham G. Walmsley | Director | SELL | $1M+ | 1.2M | $14.85 | Jun 6, 2024 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 25K | $10.30 | Jun 5, 2024 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 15K | $9.51 | May 2, 2024 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 20K | $10.97 | Mar 29, 2024 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 25K | $12.41 | Mar 4, 2024 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 30K | $12.79 | Feb 2, 2024 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 25K | $13.38 | Jan 2, 2024 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 25K | $12.57 | Dec 1, 2023 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 8K | $14.39 | Nov 23, 2023 |
| Harmon Cyrus | Director | GRANT | N/A | 16K | — | Nov 23, 2023 |
| Zojwalla Naseem | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 15K | $14.38 | Nov 23, 2023 |
| Zojwalla Naseem | CHIEF MEDICAL OFFI… | GRANT | N/A | 28K | — | Nov 23, 2023 |
| Myles David C. | CH. DISCOV. & NON-… | GRANT | N/A | 26K | — | Nov 23, 2023 |
| Myles David C. | CH. DISCOV. & NON-… | SELL | $100K–$500K | 14K | $14.40 | Nov 23, 2023 |
| Bohen Sean | PRESIDENT AND CEO | SELL | $500K+ | 57K | $14.40 | Nov 23, 2023 |
| Bohen Sean | PRESIDENT AND CEO | GRANT | N/A | 110K | — | Nov 23, 2023 |
| Kovacs Shane William Charles | CH. OPERATING & FI… | SELL | $100K–$500K | 19K | $14.39 | Nov 23, 2023 |
| Kovacs Shane William Charles | CH. OPERATING & FI… | GRANT | N/A | 37K | — | Nov 23, 2023 |
| Myles David C. | CH. DISCOV. & NON-… | SELL | $1K–$15K | 200 | $17.61 | Nov 13, 2023 |
| Myles David C. | CH. DISCOV. & NON-… | SELL | $100K–$500K | 11K | $15.26 | Nov 4, 2023 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 30K | $12.65 | Nov 3, 2023 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 25K | $12.41 | Oct 3, 2023 |
| Myles David C. | CH. DISCOV. & NON-… | SELL | $100K–$500K | 20K | $12.67 | Sep 21, 2023 |
| BVF PARTNERS L P/IL | Director | BUY | $1M+ | 1.5M | $9.84 | Sep 14, 2023 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 25K | $10.26 | Sep 6, 2023 |
| Harmon Cyrus | Director | SELL | $100K–$500K | 15K | $10.14 | Aug 17, 2023 |
| Harmon Cyrus | Director | SELL | $50K–$100K | 10K | $6.30 | Jun 9, 2023 |
| Harmon Cyrus | Director | SELL | $50K–$100K | 10K | $6.17 | Jun 8, 2023 |
| Kovacs Shane William Charles | CH. OPERATING & FI… | BUY | N/A | 10K | — | Apr 7, 2023 |
| Kovacs Shane William Charles | CH. OPERATING & FI… | BUY | N/A | 20K | — | Sep 6, 2022 |
| BVF PARTNERS L P/IL | Director | BUY | $500K+ | 200K | $4.03 | Jun 14, 2022 |
| Horn Kinney | CHIEF BUSINESS OFF… | EXERCISE | $1K–$15K | 5K | $2.06 | Mar 14, 2022 |
| Horn Kinney | CHIEF BUSINESS OFF… | SELL | $15K–$50K | 5K | $4.75 | Mar 14, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 146 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8.5M | $1M+ | SH |
| Siren, L.L.C. | 3.3M | $1M+ | SH |
| VANGUARD GROUP INC | 3.3M | $1M+ | SH |
| Logos Global Management LP | 3.2M | $1M+ | SH |
| Cormorant Asset Management, LP | 2.8M | $1M+ | SH |
| RA CAPITAL MANAGEMENT, L.P. | 2.6M | $1M+ | SH |
| Lightspeed Management Company, L.L.C. | 1.9M | $1M+ | SH |
| STATE STREET CORP | 1.9M | $1M+ | SH |
| Defilade Capital Management, L.P. | 1.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 964K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 916K | $1M+ | SH |
| Ikarian Capital, LLC | 759K | $1M+ | SH |
| Candriam S.C.A. | 679K | $1M+ | SH |
| Vivo Capital, LLC | 672K | $1M+ | SH |
| First Turn Management, LLC | 618K | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 569K | $1M+ | SH |
| Pictet Asset Management Holding SA | 503K | $1M+ | SH |
| Hennion & Walsh Asset Management, Inc. | 447K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 407K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
8.4%
6.7M shares
SC 13G/A · Feb 13, 2026
0.0%
0 shares
SC 13G · Feb 5, 2026
6.3%
5.0M shares
SC 13G · Nov 14, 2025
5.2%
3.6M shares
Point72 Asset Management, L.P.
SC 13G/A · May 15, 2025
2.3%
1.5M shares
SC 13G/A · May 15, 2025
5.0%
3.4M shares
Bain Capital Life Sciences Opportunities IV, L.P.
SC 13G/A · May 15, 2025
10.0%
6.8M shares
SC 13D/A · May 13, 2025
4.7%
3.2M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Feb 14, 2025
10.0%
7.4M shares
Bain Capital Life Sciences Opportunities IV, L.P.
SC 13G/A · Jan 13, 2025
10.0%
7.1M shares
Bain Capital Life Sciences Opportunities IV, L.P. 2
SC 13G · Dec 11, 2024
10.0%
7.5M shares
BIOTECHNOLOGY VALUE FUND, L.P.
SC 13D/A · Dec 5, 2024
6.2%
4.7M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2024
9.6%
5.5M shares
SC 13G/A · Nov 14, 2024
7.0%
4.0M shares
Point72 Asset Management, L.P.
SC 13G · Jun 14, 2024
5.7%
3.2M shares
SC 13G · Mar 22, 2024
5.4%
3.0M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Feb 14, 2024
14.3%
7.9M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2024
4.0%
2.2M shares
Kynam Capital Management, LP 85-3660072
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 12, 2024
1.3%
700K shares
SC 13G · Jan 29, 2024
6.0%
3.3M shares
BIOTECHNOLOGY VALUE FUND, L.P.
SC 13D/A · Sep 14, 2023
8.6%
4.7M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Sep 13, 2023
14.3%
7.8M shares
Paradigm BioCapital Advisors LP
SC 13G · Apr 10, 2023
6.2%
2.5M shares
SC 13G/A · Mar 21, 2023
5.0%
2.0M shares
Fairmount Funds Management LLC
SC 13G/A · Feb 14, 2023
0.0%
0 shares
Cormorant Private Healthcare Fund II, LP
SC 13G/A · Feb 14, 2023
3.9%
1.6M shares
SC 13G · Feb 10, 2023
5.0%
40.4M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 10, 2023
7.6%
3.1M shares
SC 13G/A · Nov 14, 2022
0.0%
0 shares
SC 13G · Jul 8, 2022
3.2%
1.3M shares
SC 13G/A · May 16, 2022
0.0%
0 shares
SC 13G/A · Feb 14, 2022
5.3%
2.2M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2022
0.0%
0 shares
Fairmount Funds Management LLC
SC 13G · Feb 11, 2022
5.2%
2.1M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 10, 2022
7.4%
3.0M shares